Is the PTV Margin Important for Local Control in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Definitive SBRT?

被引：0
|
作者：
Shaverdian, N. [1 ]
Wang, J. [1 ]
Veruttipong, D. [1 ]
Hegde, J. V. [1 ]
Lee, C. [1 ]
Tenn, S. E. [1 ]
Lee, P. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3097
引用
收藏
页码：E440 / E440
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Second Stereotactic Body Radiation Therapy (SBRT) for Local Recurrence of Non-small Cell Lung Cancer (NSCLC) or Lung Metastasis Previously Treated With SBRT
    Kosaki, K.
    Shibamoto, Y.
    Miyakawa, A.
    Uchiyama, K.
    Hashizume, C.
    Ogino, H.
    Murata, R.
    Mori, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S569 - S570
  • [32] Effect of Stereotactic Tracking Method on Local Control in Early Stage Non-Small Cell Lung Cancer (NSCLC)
    Braunstein, S. E.
    Descovich, M.
    Johnson, J. A.
    Pinnaduwage, D.
    Gottschalk, A.
    Yom, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S19 - S19
  • [33] Prognosis of Patients with Stage I Non-Small Cell Lung Cancer
    Flores, C. J.
    Chirinos, L.
    Enriquez, D.
    Schwarz, L. J.
    Mas, L.
    Rojas, V.
    Aguilar, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1185 - S1185
  • [34] The Patient's Perspective on SBRT for Treatment of Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Shaverdian, N.
    Wang, J.
    Steinberg, M. L.
    Lee, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E484 - E485
  • [35] Stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC)
    Dahele, M.
    Pearson, S.
    Franks, K.
    Purdie, T.
    Bissonnette, J.
    Brade, A. M.
    Cho, J.
    Sun, A.
    Jaffray, D.
    Bezjak, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Outcomes of patients with medically inoperable stage I non-small cell lung cancer (NSCLC) treated by radiation therapy (RT) alone
    Arzu, IY
    Komaki, RU
    Allen, P
    RADIOLOGY, 2000, 217 : 261 - 261
  • [37] The Impact of KRAS Mutation and PD-L1 Status on Outcomes of Definitive Stereotactic Body Radiation (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC)
    Stephans, K. L.
    Reddy, C. A.
    Videtic, G. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E391 - E392
  • [38] Specific Growth Rate in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)
    Atallah, S.
    Cook, G. G.
    MacRae, R. M.
    Cross, P.
    Bezjak, A.
    Hope, A. J.
    Pantarotto, J. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E443 - E443
  • [39] FUNCTIONAL DECLINE IN PATIENTS WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Murnane, A.
    Krishnasamy, M.
    Denehy, L.
    Granger, C.
    Aranda, S.
    Mileshkin, L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S27 - S28
  • [40] Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC)
    Ng, Dawn M.
    Sun, Alex
    Coate, Linda
    Ma, Clement
    Bezjak, Andrea
    Brade, Anthony
    Burkes, Ronald L.
    Cho, John
    Feld, Ronald
    Liu, Geoff
    Shepherd, Frances
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S858 - S858
12345